Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with <i>Haemophilus influenzae</i> Meningitis in a Newborn

Imagem de Miniatura
Arquivos
art_FERREIRA_Encephalopathy_Caused_by_Human_Parvovirus_B19_Genotype_1_2023.PDF (323.29 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
Citação
CURRENT ISSUES IN MOLECULAR BIOLOGY, v.45, n.9, p.6958-6966, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Parvovirus B19 infection is associated with a wide range of clinical manifestations, from asymptomatic to severe neurological disorders. Its major clinical symptoms, fever and rash, are common to multiple viruses, and laboratory tests to detect B19 are frequently not available. Thus, the impact of B19 on public health remains unclear. We report the case of a 38-day old girl admitted to Sao Paulo Clinical Hospital, Brazil, with an initial diagnosis of bacterial meningitis, seizures, and acute hydrocephalus. Antibiotic therapy was maintained for one week after admission and discontinued after negative laboratory results were obtained. Nine days after symptoms onset, a cerebral spinal fluid (CSF) sample revealed persistent pleocytosis. The complete B19 complete genome was subsequently identified in her CSF by a metagenomic next-generation sequencing approach. This report highlights the possible involvement of B19 in the occurrence of acute neurological manifestations and emphasizes that its possible involvement might be better revealed by the use of metagenomic technology to detect viral agents in clinical situations of unknown or uncertain etiology.
Palavras-chave
human parvovirus B19, encephalopathy, metagenomic next-generation sequencing
URI
https://observatorio.fm.usp.br/handle/OPI/57950
Referências
  1. Adamson-Small LA, 2014, VIRUS RES, V190, P8, DOI 10.1016/j.virusres.2014.06.017
  2. Bakhshi S, 2002, ARCH DIS CHILD, V87, P541, DOI 10.1136/adc.87.6.541
  3. Barah F, 2001, LANCET, V358, P729, DOI 10.1016/S0140-6736(01)05905-0
  4. Barah F, 2014, REV MED VIROL, V24, P154, DOI 10.1002/rmv.1782
  5. BROWN KE, 1994, NEW ENGL J MED, V330, P1192, DOI 10.1056/NEJM199404283301704
  6. Butler DF, 2018, INFECT DIS CLIN N AM, V32, P119, DOI 10.1016/j.idc.2017.10.005
  7. Callon D, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10080958
  8. Cao J, 2020, J NEUROVIROL, V26, P980, DOI 10.1007/s13365-020-00885-6
  9. Garcia RDC, 2021, FUTURE MICROBIOL, V16, P37, DOI 10.2217/fmb-2020-0123
  10. Conteville LC, 2015, MEM I OSWALDO CRUZ, V110, P820, DOI 10.1590/0074-02760150261
  11. COOLING LLW, 1995, J INFECT DIS, V172, P1198, DOI 10.1093/infdis/172.5.1198
  12. Cotmore SF, 2019, J GEN VIROL, V100, P367, DOI 10.1099/jgv.0.001212
  13. da Costa AC, 2013, CLIN MICROBIOL INFEC, V19, pE31, DOI 10.1111/1469-0691.12058
  14. de Oliveira MI, 2017, REV ASSOC MED BRAS, V63, P224, DOI 10.1590/1806-9282.63.03.224
  15. DEMIRANDA MFR, 1989, REV INST MED TROP SP, V31, P359, DOI 10.1590/S0036-46651989000500011
  16. Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
  17. Di Paola N, 2019, CLIN INFECT DIS, V68, P810, DOI 10.1093/cid/ciy630
  18. Druschky K, 2000, J NEUROVIROL, V6, P418, DOI 10.3109/13550280009018306
  19. Erdman DD, 1996, J GEN VIROL, V77, P2767, DOI 10.1099/0022-1317-77-11-2767
  20. Erol I, 2006, J CHILD NEUROL, V21, P820, DOI 10.1177/08830738060210092301
  21. Freitas RB, 2008, J CLIN VIROL, V43, P60, DOI 10.1016/j.jcv.2008.03.033
  22. Ganaie SS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00166
  23. Garcia SD, 2011, J CLIN MICROBIOL, V49, P1578, DOI 10.1128/JCM.00077-11
  24. Greco F, 2008, J CHILD NEUROL, V23, P1078, DOI 10.1177/0883073808315420
  25. Grillo E, 2009, DEV MED CHILD NEUROL, V51, P759, DOI 10.1111/j.1469-8749.2009.03388.x
  26. Guan HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/s13365-015-0390-7
  27. Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002
  28. Huatuco EMM, 2008, REV SAUDE PUBL, V42, P443, DOI 10.1590/S0034-89102008000300008
  29. Hübschen JM, 2009, J CLIN MICROBIOL, V47, P3735, DOI 10.1128/JCM.01201-09
  30. Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
  31. Kerr JR, 2002, J NEUROL NEUROSUR PS, V73, P739, DOI 10.1136/jnnp.73.6.739
  32. Kishore J, 2009, J TROP PEDIATRICS, V55, P335, DOI 10.1093/tropej/fmp004
  33. Krell S, 2003, INFECTION, V31, P353, DOI 10.1007/s15010-003-3091-8
  34. Lunardi C, 2008, AUTOIMMUN REV, V8, P116, DOI 10.1016/j.autrev.2008.07.005
  35. Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996
  36. Monteiro VS, 2021, J TROP PEDIATRICS, V67, DOI 10.1093/tropej/fmab078
  37. NASCIMENTO JP, 1990, REV I MED TROP, V32, P41, DOI 10.1590/S0036-46651990000100007
  38. Oliveira M.I.d., 2011, Rev. Pan-Amaz. De Saude, V2, P71, DOI [10.5123/S2176-62232011000200010, DOI 10.5123/S2176-62232011000200010]
  39. Pabbaraju K, 2015, MOL CELL PROBE, V29, P81, DOI 10.1016/j.mcp.2015.02.001
  40. Pattabiraman C, 2022, MICROBIOL SPECTR, V10, DOI 10.1128/spectrum.02251-21
  41. Perlejewski K, 2015, J VIROL METHODS, V226, P1, DOI 10.1016/j.jviromet.2015.09.010
  42. Lima LRP, 2017, MEM I OSWALDO CRUZ, V112, P220, DOI 10.1590/0074-02760160354
  43. Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16
  44. Alves ADR, 2019, EXPERT REV MOL DIAGN, V19, P259, DOI 10.1080/14737159.2019.1582333
  45. Russo DO, 2022, PEDIATR INFECT DIS J, V41, P108, DOI 10.1097/INF.0000000000003391
  46. Servant-Delmas A, 2009, TRANSFUS CLIN BIOL, V16, P482, DOI 10.1016/j.tracli.2009.09.001
  47. Slavov SN, 2019, J MED VIROL, V91, P1224, DOI 10.1002/jmv.25453
  48. Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120
  49. Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001
  50. Vilmane A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10060339
  51. WAGNER AD, 1995, MAYO CLIN PROC, V70, P261, DOI 10.4065/70.3.261
  52. Watanabe Toru, 2015, World J Clin Pediatr, V4, P126, DOI 10.5409/wjcp.v4.i4.126
  53. Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522
  54. Yazawa S, 2002, CLIN NEUROL NEUROSUR, V104, P380, DOI 10.1016/S0303-8467(02)00030-6
  55. Yetgin S, 2000, EUR J HAEMATOL, V65, P276, DOI 10.1034/j.1600-0609.2000.065004276.x
  56. Zimmerman SA, 2003, J PEDIAT HEMATOL ONC, V25, P387, DOI 10.1097/00043426-200305000-00007

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/31
Carregar mais